Samuel Bates Martin's Net Worth
Samuel Bates Martin's net worth is estimated to be at least $3,405,532.39 as of 11/23/2024. CoreStreet's estimation of Samuel Bates Martin's net worth is based on their sale of stock and current holding of stock.
Samuel Bates Martin is CFO at Celldex Therapeutics Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 17,172 units of CLDX stock on 06/14/2024. Their biggest sale was on 05/30/2024 when they sold 35,000 units of Celldex Therapeutics Inc stock for $1,191,750.00. They typically trade 1 times per year.
Total value of insider buys:
- $29,152.50
Total value of insider sells:
- $3,376,379.89
Most recent insider trade:
- June 14, 2024
Samuel Bates Martin's Insider Trading History
| Celldex Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 14, 2024 | CFO | 17,172 | $35.42 | Sell | $608,232.24 |
May 30, 2024 | CFO | 35,000 | $34.05 | Sell | $1,191,750.00 |
Aug. 12, 2022 | CFO | 17,547 | $36.45 | Sell | $639,588.15 |
Dec. 23, 2021 | CFO | 9,500 | $42.00 | Sell | $399,000.00 |
Nov. 15, 2021 | CFO | 9,500 | $43.57 | Sell | $413,915.00 |
Aug. 10, 2021 | CFO | 2,738 | $45.25 | Sell | $123,894.50 |
June 9, 2020 | CFO | 9,750 | $2.99 | Buy | $29,152.50 |